Overview

Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Our aims were to determine if exhaled breath condensate (EBC) could detect differences in ion regulation between cystic fibrosis (CF) and healthy and measure the effect of the albuterol on EBC ions in these populations. We hypothesized EBC chloride and sodium would be lower in CF patients at baseline and that albuterol would decrease EBC sodium and increase EBC chloride.
Phase:
N/A
Details
Lead Sponsor:
University of Arizona
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Albuterol